2,3-disubstituted pyrazinesulfonamides as CRTH2 inhibitors
US8796280B2 · kind B2 · utility
11Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 20, 2006 |
| Grant date | Aug 5, 2014 |
| Priority date | — |
| Expiry date | Apr 20, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is related to the use of 2,3 substituted pyrazine sulfonamides of formula (I)for the treatment and/or prevention of allergic diseases, inflammatory dermatoses and other diseases with an inflammatory component. Specifically, the present invention is related to the use of 2,3 substituted pyrazine sulfonamides for the modulation, notably the inhibition, of CRTH2 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.